About us
Leading Innovation in Therapeutic Development
FluoTech Biosciences Limited emerges from groundbreaking research in Metal-Organic Framework (MOF) technology and drug delivery systems. Established in 2023 through the Hong Kong Science and Technology Park (HKSTP) program, we combine expertise in materials science and biomedical engineering to create revolutionary solutions for both research and theragnostic applications.
FTB-728
Metal-Organic Frameworks represent a revolutionary class of crystalline materials that combine metal ions with organic molecules to create highly ordered, three-dimensional structures. Think of them as molecular building blocks that can be precisely engineered to create materials with extraordinary properties.
Specialized functions:
• Have high anti-inflammatory drug loading
• PEG crown for stability and long-time circulation
• Atherosclerosis plaque targeting peptide (RGD).
Target Users
Our products are to be used by the scientific community
Universities
Universities for research purposes
Science institutes
To be used in drug delivery testing
State Key laboratory
To be used in drug delivery testing
Service Excellence
We offer Three services:
Therapeutic Innovation: ATHRICINE
A nano-platform loaded with Colchicine for drug delivery (for atherosclerosis)
FTB-728 Drug delivery nanoplatform
A nano-platform that can be modified for drug delivery
Advanced Research materials: FTB-728
Nanomaterials that can be used by different research institutes.
Contact us
Got questions or ready to start our product? Don’t hesistate to reach out.